Novel Biologic Therapies for Malignant Gliomas

This publication has 80 references indexed in Scilit:

• Thalidomide is an inhibitor of angiogenesis.
  Proceedings of the National Academy of Sciences, 1994
• Progressive modulation of endothelial phenotype during in vitro blood vessel formation
  Developmental Biology, 1991
• Intralesional interferon therapy for basal cell carcinoma
  Journal of the American Academy of Dermatology, 1990
• What Is the Evidence That Tumors Are Angiogenesis Dependent?
  JNCI Journal of the National Cancer Institute, 1990
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-gamma
  International Journal of Cancer, 1985
• Clinical effect of interferon in malignant brain tumours
  Neurosurgical Review, 1984
• Inhibition of ornithine decarboxylase in human fibroblast cells by type I and type II interferons
  Biochemical and Biophysical Research Communications, 1983
• Tumor Angiogenesis: Therapeutic Implications
  New England Journal of Medicine, 1971
• Heterologous, homologous, and autologous transplantation of human tumors
  Cancer, 1963